![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Influenza |
Free Subscription
1 Arch Virol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Influenza is free of charge.
Genetic diversity of rotavirus A in Argentina during 2019-2022: detection of G6
strains and insights regarding its dissemination.
Arch Virol. 2023;168:251.
PubMed
Abstract available
How can I support my colleague returning to work with long covid?
BMJ. 2023;382:p1997.
PubMed
What happens inside a long covid clinic?
BMJ. 2023;382:1791.
PubMed
Fluconazole and echinocandin resistance of Candida species in invasive
candidiasis at a university hospital during pre-COVID-19 and the COVID-19
outbreak.
Epidemiol Infect. 2023;151:e146.
PubMed
Abstract available
Understanding the impact of the COVID-19 pandemic response on GI infection
surveillance trends in England, January 2020-April 2022.
Epidemiol Infect. 2023;151:e147.
PubMed
Abstract available
A systematic review of the evidence on the associations and safety of COVID-19
vaccination and post COVID-19 condition.
Epidemiol Infect. 2023;151:e145.
PubMed
Abstract available
Ethnic inequalities in positive SARS-CoV-2 tests, infection prognosis, COVID-19
hospitalisations and deaths: analysis of 2 years of a record linked national
cohort study in Scotland.
J Epidemiol Community Health. 2023;77:641-648.
PubMed
Abstract available
SARS-CoV-2 infections in migrants and the role of household overcrowding: a
causal mediation analysis of Virus Watch data.
J Epidemiol Community Health. 2023;77:649-655.
PubMed
Abstract available
Allergen exposure functionally alters influenza-specific CD4+ Th1 memory cells in
the lung.
J Exp Med. 2023;220:e20230112.
PubMed
Abstract available
Genetic Variant in Complement Receptor 1 (CR1, CD35) is Associated with A Cluster
of Severe Fatal COVID-19 in a Family.
J Infect. 2023 Mar 14:S0163-4453(23)00143-3. doi: 10.1016/j.jinf.2023.
PubMed
The effect of molnupiravir on post-acute outcome of COVID-19 survivors.
J Infect. 2023 Mar 21:S0163-4453(23)00145-7. doi: 10.1016/j.jinf.2023.
PubMed
Incidence of tuberculosis infection in healthcare workers in high-risk
departments for tuberculosis after universal wearing of KF94 mask during COVID-19
pandemic.
J Infect. 2023 Mar 21:S0163-4453(23)00146-9. doi: 10.1016/j.jinf.2023.
PubMed
SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months
post-infection, irrespective of disease severity.
J Infect. 2023 Jun 7:S0163-4453(23)00302-X. doi: 10.1016/j.jinf.2023.
PubMed
The association between zinc deficiency, and clinical outcomes of COVID-19.
J Infect. 2023 Jun 29:S0163-4453(23)00343-2. doi: 10.1016/j.jinf.2023.
PubMed
Artificial Intelligence, Machine Learning and Deep Learning: Potential Resources
for the Infection Clinician.
J Infect. 2023 Jul 17:S0163-4453(23)00379-1. doi: 10.1016/j.jinf.2023.
PubMed
Abstract available
Genetic diversity and its impact on disease severity in respiratory syncytial
virus subtype-A and -B bronchiolitis before and after pandemic restrictions in
Rome.
J Infect. 2023 Jul 24:S0163-4453(23)00381-X. doi: 10.1016/j.jinf.2023.
PubMed
Abstract available
Investigation of escape mechanisms of SARS-CoV-2 Omicron sub-lineages and
exploration of potential antibodies for XBB.1.
J Infect. 2023 Jul 26:S0163-4453(23)00387-0. doi: 10.1016/j.jinf.2023.
PubMed
Saliva antiviral antibody levels are detectable but correlate poorly with serum
antibody levels following SARS-CoV-2 infection and/or vaccination.
J Infect. 2023 Aug 3:S0163-4453(23)00439-5. doi: 10.1016/j.jinf.2023.
PubMed
Abstract available
COVID-19 vaccine effectiveness against hospitalisation and death of people in
clinical risk groups during the Delta variant period: English primary care
network cohort study.
J Infect. 2023 Aug 12:S0163-4453(23)00456-5. doi: 10.1016/j.jinf.2023.
PubMed
Abstract available
Distribution and risks of the infections of humans and other mammals with H5
subtype highly pathogenic avian influenza viruses in 2020-2023.
J Infect. 2023 Sep 7:S0163-4453(23)00505-4. doi: 10.1016/j.jinf.2023.
PubMed
What to Know About EG.5, the Latest SARS-CoV-2 "Variant of Interest".
JAMA. 2023 Aug 18. doi: 10.1001/jama.2023.16498.
PubMed
Lung Transplants for COVID-19 Similarly Successful.
JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.15450.
PubMed
Two New Analyses Add to Long COVID Understanding.
JAMA. 2023;330:905-906.
PubMed
Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in
Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July
2023.
MMWR Morb Mortal Wkly Rep. 2023;72:1010-1015.
PubMed
Wastewater Surveillance Data as a Complement to Emergency Department Visit Data
for Tracking Incidence of Influenza A and Respiratory Syncytial Virus -
Wisconsin, August 2022-March 2023.
MMWR Morb Mortal Wkly Rep. 2023;72:1005-1009.
PubMed
Abstract available
Progress Toward Measles Elimination - African Region, 2017-2021.
MMWR Morb Mortal Wkly Rep. 2023;72:985-991.
PubMed
Abstract available
Estimating the epidemic reproduction number from temporally aggregated incidence
data: A statistical modelling approach and software tool.
PLoS Comput Biol. 2023;19:e1011439.
PubMed
Abstract available
Scoring epidemiological forecasts on transformed scales.
PLoS Comput Biol. 2023;19:e1011393.
PubMed
Abstract available
Daily disease severity in patients with COVID-19 admitted to the hospital: The
SCODA (severity of coronavirus disease assessment) score.
PLoS One. 2023;18:e0291212.
PubMed
Abstract available
The association between depression and addictive social media use during the
COVID-19 pandemic: The mediating role of sense of control.
PLoS One. 2023;18:e0291034.
PubMed
Abstract available
Risk factors for mortality among lung cancer patients with covid-19 infection: A
systematic review and meta-analysis.
PLoS One. 2023;18:e0291178.
PubMed
Abstract available
Utilization of digital tools to enhance COVID-19 and tuberculosis testing and
linkage to care: A cross-sectional evaluation study among Bodaboda motorbike
riders in the Nairobi Metropolis, Kenya.
PLoS One. 2023;18:e0290575.
PubMed
Abstract available
Different aspects in explaining how mutations could affect the binding mechanism
of receptor binding domain of SARS-CoV-2 spike protein in interaction with ACE2.
PLoS One. 2023;18:e0291210.
PubMed
Abstract available
Post-acute sequelae of COVID-19 and longitudinal antibody levels in a
community-based cohort.
PLoS One. 2023;18:e0291259.
PubMed
Abstract available
Canadians' trust in government in a time of crisis: Does it matter?
PLoS One. 2023;18:e0290664.
PubMed
Abstract available
Association between wealth, insurance coverage, urban residence, median age and
COVID-19 deaths across states in Nigeria.
PLoS One. 2023;18:e0291118.
PubMed
Abstract available
Pre-pandemic activity on a myalgic encephalomyelitis/chronic fatigue syndrome
support forum is highly associated with later activity on a long COVID support
forum for a variety of reasons: A mixed methods study.
PLoS One. 2023;18:e0291173.
PubMed
Abstract available
Modelling sovereign credit ratings and assessing the impartiality: A case study
of China.
PLoS One. 2023;18:e0289321.
PubMed
Abstract available
An analysis of pain intensity, injury incidence, and their associations with
socio-demographic factors in high school athletes: A cross-sectional study during
the COVID-19 pandemic.
PLoS One. 2023;18:e0290587.
PubMed
Abstract available
Differences in perceptions and acceptance of COVID-19 vaccination between vaccine
hesitant and non-hesitant persons.
PLoS One. 2023;18:e0290540.
PubMed
Abstract available
Extending the Omega model with momentum and reversal strategies to intraday
trading.
PLoS One. 2023;18:e0291119.
PubMed
Abstract available
Vitamin D deficiency and SARS?CoV?2 infection: A retrospective case-Control study
with big-data analysis covering March 2020 to March 2021.
PLoS One. 2023;18:e0277388.
PubMed
Abstract available
The impact of the early COVID-19 pandemic on healthcare system resource use and
costs in two provinces in Canada: An interrupted time series analysis.
PLoS One. 2023;18:e0290646.
PubMed
Abstract available
The Gull Alpha Power Lomax distributions: Properties, simulation, and
applications to modeling COVID-19 mortality rates.
PLoS One. 2023;18:e0283308.
PubMed
Abstract available
Cross-sectional study on public health knowledge among first-year university
students in Japan: Implications for educators and educational institutions.
PLoS One. 2023;18:e0291414.
PubMed
Abstract available
One-fourth of COVID-19 patients have an impaired pulmonary function after 12
months of disease onset.
PLoS One. 2023;18:e0290893.
PubMed
Abstract available
Targeting spike glycans to inhibit SARS-CoV2 viral entry.
Proc Natl Acad Sci U S A. 2023;120:e2301518120.
PubMed
Abstract available
Individual and structural determinants of COVID-19 vaccine uptake in a
marginalized community in the United States.
Vaccine. 2023 Aug 5:S0264-410X(23)00923-4. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Political quarrel overshadows vaccination advocacy: How the vaccine debate on
Brazilian Twitter was framed by anti-vaxxers during Bolsonaro administration.
Vaccine. 2023 Aug 5:S0264-410X(23)00921-0. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Performance comparison between heterologous and homologous COVID19 vaccine
schedules on Omicron variant incidence: A real-world retrospective cohort study
in Southern Italy.
Vaccine. 2023 Aug 9:S0264-410X(23)00886-1. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and
socially unequal Brazilian city: A target trial emulation study.
Vaccine. 2023;41:5742-5751.
PubMed
Abstract available
Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19
vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A
multicenter, prospective, double-blind, randomized control trial.
Vaccine. 2023 Aug 14:S0264-410X(23)00953-2. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Optimal site of care for administration of extended half-life respiratory
syncytial virus (RSV) antibodies to infants in the United States (US).
Vaccine. 2023;41:5820-5824.
PubMed
Abstract available
Are intelligent people more likely to get vaccinated? The association between
COVID-19 vaccine adherence and cognitive profiles.
Vaccine. 2023 Aug 15:S0264-410X(23)00951-9. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: Two
retrospective cohort analyses of the primary schedule and third dose.
Vaccine. 2023 Aug 17:S0264-410X(23)00916-7. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by
heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic
obstructive pulmonary disease.
Vaccine. 2023 Aug 18:S0264-410X(23)00966-0. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Predictors of immune persistence induced by two-dose BBIBP-CorV vaccine in
high-risk occupational population.
Vaccine. 2023 Aug 19:S0264-410X(23)00974-X. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
COVID-19 vaccine decision-making among Black women: A qualitative study.
Vaccine. 2023 Aug 24:S0264-410X(23)00920-9. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
A recombinant chimeric influenza virus vaccine expressing the consensus H3
hemagglutinin elicits broad hemagglutination inhibition antibodies against
divergent swine H3N2 influenza viruses.
Vaccine. 2023 Sep 7:S0264-410X(23)01060-5. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated
influenza vaccines in the prevention of influenza-related hospitalization in
older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS)
Network of the Canad
Vaccine. 2023 Sep 9:S0264-410X(23)01026-5. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
AMFR promotes innate immunity activation and proteasomal degradation of HMGCR in
response to influenza virus infection in A549 cells.
Virology. 2023;587:109875.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by